Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/06/1996 | CN1135161A Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds |
11/06/1996 | CN1134941A New pseudopeptides having trifluoromethyl substtuted 2-azazbicyclooctane |
11/06/1996 | CN1134939A Method for prepn. of 3-formyl-cephem derivatives |
11/06/1996 | CN1134938A Novel alkylated (hetero) cyclic compounds, process for their prepn. and pharmaceutical compositions contg. same |
11/06/1996 | CN1134932A Substituted benzene sulfonyl urea and benzene sulfonyl thiourea and mfg. method and use as raw material for medicine |
11/06/1996 | CN1134833A Composite pharmaceutics for curing dysentery |
11/06/1996 | CN1134828A Medicine for treating hircismus |
11/06/1996 | CN1134801A Medicinal towel and shoe pad for treating beriberi |
11/06/1996 | CN1033227C Method for prepn. of pyrimidine nucleoside derivatives having anti-tumor activity |
11/06/1996 | CN1033214C Capsul for curing gastric ulcer |
11/06/1996 | CN1033209C Using sinapine as raw material for prepn. solution for preventing radiation injury |
11/06/1996 | CN1033208C Using L-Lysine chlorhydric salt as raw material for prepn. of hemostatic |
11/06/1996 | CN1033207C L-Lysine chlorhydric salt for treating injured skull |
11/06/1996 | CA2175747A1 Benzopyrane derivatives used for preparing pharmaceutical compositions used in the treatment of pathology related to na+ independent cl-/hco3- exchanger |
11/06/1996 | CA2174583A1 Sulfuric acid esters of sugar alcohols |
11/06/1996 | CA2174582A1 Sulphuric acid esters of amino-sugars |
11/05/1996 | US5571942 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes |
11/05/1996 | US5571937 Complementary DNA and toxins |
11/05/1996 | US5571925 Angiotensin II antagonists |
11/05/1996 | US5571923 3-/1-dodecyl/-5-isoxazolemethanol intermediate |
11/05/1996 | US5571921 Substituted (2-oxo-1-benzimidazolinyl)-peperidines, process for their preparation, and use as anti-retroviral agents |
11/05/1996 | US5571918 Reacting 3-hydroxy-3-mercaptomethylquinuclidine and a carbonyl compound in the presence of a catalyst |
11/05/1996 | US5571917 Taxoid intermediates |
11/05/1996 | US5571914 Antitumor agents |
11/05/1996 | US5571902 Synthesis of oligonucleotides |
11/05/1996 | US5571900 Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof |
11/05/1996 | US5571846 Method of inhibiting fibrosis |
11/05/1996 | US5571845 Nitroaniline derivatives and their use as anti-tumour agents |
11/05/1996 | US5571844 Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants |
11/05/1996 | US5571843 Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof |
11/05/1996 | US5571842 Perfluoroalkyl-substituted, benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them |
11/05/1996 | US5571841 Treating skin with mandelic acid for wrinkle reduction |
11/05/1996 | US5571840 Method for treating central nervous system ischemia |
11/05/1996 | US5571839 D-aspartic acid β-hydroxamate for the treatment of viral infections and tumors |
11/05/1996 | US5571837 Method of treating wrinkles using saccharic acid or saccharolactone |
11/05/1996 | US5571836 Neuraminic acid derivatives |
11/05/1996 | US5571835 Inhibitors of farnesyl-protein transferase |
11/05/1996 | US5571834 Pharmaceutical composition useful for the treatment of cardiovascular diseases |
11/05/1996 | US5571833 Tryptamine analogues, their synthesis and their use as 5-HT1 -like or 5-HT2 receptor agonists |
11/05/1996 | US5571828 N-[(3-heteroaryl-1-pyrrolidinyl)alkyl]-2,3-napthalimides and related compounds and their therapeutic utility |
11/05/1996 | US5571827 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine |
11/05/1996 | US5571826 Heterocyclic compounds and their preparation and use |
11/05/1996 | US5571825 Method of selectively inhibiting prostaglandin G/H synthase-2 |
11/05/1996 | US5571823 Pharmacological treatment of ocular development |
11/05/1996 | US5571822 Antitumor compounds |
11/05/1996 | US5571818 Pyrrolyl-4h-pyranoisoquinolines |
11/05/1996 | US5571817 Which are testosterone-reductase inhibitors;topical application |
11/05/1996 | US5571816 Pyrimidines |
11/05/1996 | US5571814 N-[(4-heteroaryl-1-pyrrolidinyl)alkyl]phthalimides and related compounds and their therapeutic utility |
11/05/1996 | US5571813 Treatment of hypertension, congestive heart failure, renal failure |
11/05/1996 | US5571812 7-amino-1-cyclopropyl-6,8-dihalogeno-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid antibacterial agents |
11/05/1996 | US5571811 Treating helicobacter infection |
11/05/1996 | US5571808 Substituted 2-aryl-3-aroylbenzo(b)thiophenes |
11/05/1996 | US5571807 Calcium antagonists, treatment of angina and hypertension |
11/05/1996 | US5571806 Dibenz[b,f][1,4]oxazepin(and thiazepin)-11(10H)-ones and-thiones and their use in the prevention or treatment of HIV infection |
11/05/1996 | US5571805 Antibiotic compounds |
11/05/1996 | US5571804 Cephalosporin antibiotics |
11/05/1996 | US5571803 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
11/05/1996 | US5571802 Method of treating post menopausal osteoporosis with hexafluro-vitamin D |
11/05/1996 | US5571801 Plasma expander and blood substitute |
11/05/1996 | US5571800 Method for inhibiting allograft rejection by the administration of 6-azauridine or its triacetate derivative |
11/05/1996 | US5571798 Synergistic antiviral nucleoside combinations |
11/05/1996 | US5571795 Glycosylated steroids coupled to a drug, transportation across biological membranes |
11/05/1996 | US5571793 Combatting endoparasites in humans or animals by administering peptides |
11/05/1996 | US5571792 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
11/05/1996 | US5571783 Composition and method for treating patients with hepatic disease |
11/05/1996 | US5571689 Method of N-acylating peptide and proteins with diheteroatom substituted analogs of myristic acid |
11/05/1996 | US5571671 Detection of mosaic population of cells with two or three copies of chromosome 21 |
11/05/1996 | US5571666 Thiazine dyes used to inactivate HIV in biological fluids |
11/05/1996 | US5571534 Drug formulations for parenteral use |
11/05/1996 | US5571533 Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide |
11/05/1996 | US5571530 Respiratory system disorders by administering beta receptors for treatment of bronchitis |
11/05/1996 | US5571528 Pilocarpine-containing chewing gum that stimulates salivation |
11/05/1996 | US5571524 Diadenosine tetraphosphate |
11/05/1996 | US5571523 Antioxidant-induced apoptosis in vascular smooth muscle cells |
11/05/1996 | US5571518 Proliferation of skin |
11/05/1996 | US5571506 Aromatic oligomeric compounds useful as mimics of bioactive macromolecules |
11/05/1996 | US5571505 Anti-HIV oligomers |
11/05/1996 | US5571501 Denyifrice |
11/05/1996 | US5571186 Porous hydroxyapatite or tricalcium phosphate, 7-isopropoxyisoflavone |
11/05/1996 | US5570683 Methods and devices for treating pulmonary vasoconstriction and asthma |
11/05/1996 | CA2098102C Alteration of rate and character of hair growth |
11/03/1996 | CA2175293A1 Pharmaceutical preparations having controlled release of active compound and processes for their preparation |
10/31/1996 | WO1996034109A1 Single-vial formulations of dna/lipid complexes |
10/31/1996 | WO1996034106A1 Decorin binding protein compositions and methods of use |
10/31/1996 | WO1996034099A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
10/31/1996 | WO1996034095A1 Human tumor necrosis factor receptors |
10/31/1996 | WO1996034006A1 Antigenic carbohydrate derivatives and process for producing the same |
10/31/1996 | WO1996034005A1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
10/31/1996 | WO1996033999A1 NOVEL SUBSTITUTED TETRAHYDROPYRANO[3,2-d]OXAZOLONES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
10/31/1996 | WO1996033985A1 Piperidine derivatives as diuretic |
10/31/1996 | WO1996033984A1 N-sulfoxy anhydrides, a process for the preparation thereof and its use for the preparation of bioactive substances having ace inhibitory action |
10/31/1996 | WO1996033981A1 Quinazoline derivative |
10/31/1996 | WO1996033980A1 Quinazoline derivatives |
10/31/1996 | WO1996033979A1 Quinazoline derivatives |
10/31/1996 | WO1996033978A1 Quinazoline derivative |
10/31/1996 | WO1996033977A1 Quinazoline derivatives |
10/31/1996 | WO1996033970A1 Substituted phenyl amidines, medicaments containing these compounds and process for producing them |
10/31/1996 | WO1996033968A1 Highly water-soluble metalloproteinase inhibitor |
10/31/1996 | WO1996033745A1 Formulations for lipophilic compounds |